predict-rt study for patients with high-risk prostate cancer
Published 1 year ago • 1.2K plays • Length 5:02Download video MP4
Download video MP3
Similar videos
-
0:20
”as a prostate cancer patient, how will the nrg-gu010 trial benefit me?”
-
3:13
nrg-gu013, the "high five" trial interview for sites
-
2:56
prostate cancer clinical trial: rtire
-
0:26
the #rtire trial is now recruiting patients with intermediate-risk prostate cancer.
-
1:40
prostate cancer clinical trial nrg-gu010 (part 1/3)
-
2:10
clinical trial nrg-gu010: patient video 2
-
2:09
clinical trial nrg-gu010: patient video 3
-
4:19
ai-derived pathology-based biomarker predicts benefit of ltadt with rt in localised high-risk pc
-
0:49
”what is the rtire clinical trial aiming to achieve?”
-
0:52
”how do gene scores impact my treatment for prostate cancer?”
-
0:24
”as a prostate cancer patient, how can the nrg-gu010 trial help tailor treatment to my needs?"
-
3:21
prostate cancer clinical trial: the innovate trial (nrg-gu008)
-
1:10
dr. nguyen on future research in high-risk prostate cancer
-
3:22
therapy approach in high-risk prostate cancer
-
0:53
“i have prostate cancer—how can adding apalutamide to standard treatment improve my outcomes?”
-
2:45
new clinical trial to examine high risk prostate cancer patients
-
5:00
advanced prostate cancer clinical trials | access and nrg-gu008 trial
-
4:28
predicting pathological outcomes in patients undergoing rarp for high-risk prostate cancer
-
3:01
prostate cancer clinical trial: metanova trial